The National Home Infusion Foundation (NHIF) recently released the Q2 results for the benchmarking program for home infusion patient satisfaction.
Read the open access report
NHIA members are encouraged to review the draft benchmarking participation guides for collecting industry-wide outcome data for 30-day Rehospitalizations, and the Status at Discharge for patients receiving infusions in the home or suite setting. A revised definition for the Discharge Reasons is also proposed to support data collection for the new benchmarking metrics. Deadline to submit comment is December 31. Send comments to email@example.com.
See all documents
The National Home Infusion Foundation (NHIF) recently released the Q1 results-establishing the first industry-wide benchmarks for home infusion patient satisfaction. Survey results from 1,369 program participants, representing 6,958 patients found that home and specialty infusion patients are very satisfied with their care.
Download the open access report to see more details.
Get an update on the NHIF data initiatives by playing the video above. To learn more about the initiative and enrollment, please click here.
On March 12, the National Home Infusion Foundation (NHIF) presented the Outstanding Abstract Achievement Award to Jessica Das, PharmD, Pharmacy Resident at Fairview Home Infusion. Das’ abstract, “Risk Factors Associated with Clostridium difficile Infections in Home Infusion Patients,” identified the most frequent factors associated with C. diff and evaluated home infusion patient risk. A manuscript describing Das’ research will be published in an upcoming issue of INFUSION. Das was awarded a $1000 scholarship and complimentary registration to the 2020 NHIA Annual Conference.
View Abstract Slides
NHIF has plans to initiate several industry-wide data collection and reporting activities in 2019, starting with Patient Satisfaction Benchmarking. NHIF also has plans to collect data in 2019 that will allow the Foundation to publish a report summarizing the business trends in the home infusion industry. In order to streamline how the data for various benchmarks will be reported and analyzed, it is necessary to develop a standardized list of therapy categories for use in data analysis and cross-tabulations. Therefore, NHIF is releasing the proposed list of therapy categories that will be used in the initial benchmarking program. Providers may wish to collect more detailed therapy category data at an organizational level; however the more detailed data can be mapped to the broader category for national reporting purposes. NHIF recognizes that individual differences exist with regard to the clinical terminology used today. NHIF also recognizes that some adaptation will need to occur to achieve standardization with these outcome data elements. The standardized definitions being proposed are intended to be broad enough to accommodate variations in software and data collection processes between providers. If you have questions or comments about the proposed list of therapy categories, please send your comments to Connie Sullivan, Vice President of Research and Innovation at firstname.lastname@example.org.
Click here to see the list.
On July 31, 2018, the National Home Infusion Foundation (NHIF) will launch the initial pilot phase of the first industry-wide benchmarking program regarding patient satisfaction with home infusion services. Patient satisfaction benchmarking will enable the establishment and publication of a national standard, making it possible for individual providers to compare their data and performance against industry norms. Providers who adopt the questions published by NHIF in 2017 and who meet additional criteria developed through work with the NHIA Outcomes Task Force, will be eligible to participate in the benchmarking program starting January 2019. Additional information regarding the Patient Satisfaction Benchmarking program will be published in the July/August issue of INFUSION magazine. Questions about the program can be sent to Connie Sullivan, Vice President of Research and Innovation at email@example.com.